5 Best Mid-Cap Stocks That Could Double Your Money

In this article, we will list the 5 Best Mid-Cap Stocks That Could Double Your Money. Please visit 10 Best Mid-Cap Stocks That Could Double Your Money if you’d like to see an extended list and the methodology behind it.

5. Structure Therapeutics Inc. (NASDAQ:GPCR)

Structure Therapeutics Inc. (NASDAQ:GPCR) is one of the 10 best mid-cap stocks that could double your money.

On June 11, H.C. Wainwright reduced its price target on Structure Therapeutics Inc. (NASDAQ:GPCR) from $100 to $70, which still leads to an adjusted upside potential of more than 61%. The firm upheld its Buy rating on the stock.

Source:unsplash

H.C. Wainwright noted that Retatrutide’s clean low-dose profile alongside Pfizer’s once-monthly injectable establishes a new benchmark within the identical mid-body mass index market that oral treatments are targeting. Consequently, the firm cited increasing competitive pressure as the primary reason for the price target reduction.

On June 6, Structure Therapeutics Inc. (NASDAQ:GPCR) announced Phase 2b ACCESS trial results for aleniglipron in Nature Medicine. A lower 2.5 mg starting dose improved tolerability. Furthermore, weight loss persisted beyond 36 weeks, shaping the Phase 3 trials scheduled for the third quarter of 2026.

Patients actually kept shedding weight during the extension phase without hitting a plateau. According to Steering Committee Chair Dr. Julio Rosenstock, MD, this continuous weight loss makes the daily oral drug a highly unique option for patients.

Structure Therapeutics Inc. (NASDAQ:GPCR) is involved in the development and marketing of novel oral small molecule therapies for the treatment of several chronic diseases with unmet medical needs. The company is currently working on several drug candidates, which include GSBR-1290, ACCG-2671, ACCG-3535, LTSE-2578, and ANPA-0073. Additionally, it also develops programs like the GCG and GIPR programs.